{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:50:08Z","timestamp":1787064608851,"version":"build-2736575974"},"reference-count":60,"publisher":"Elsevier BV","issue":"15-16","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.drudis.2013.04.005","type":"journal-article","created":{"date-parts":[[2013,4,19]],"date-time":"2013-04-19T03:03:33Z","timestamp":1366340613000},"page":"748-755","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Non-peptidyl insulin mimetics as a potential antidiabetic agent"],"prefix":"10.1016","volume":"18","author":[{"given":"Rakesh P.","family":"Nankar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mukesh","family":"Doble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.drudis.2013.04.005_bib0005","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.2337\/dc11-S062","article-title":"Diagnosis and Classification of Diabetes Mellitus","volume":"34","author":"American Diabetes Association","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.drudis.2013.04.005_bib0010","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/med.20142","article-title":"Recent and emerging anti diabetes targets","volume":"29","author":"Mohler","year":"2009","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.drudis.2013.04.005_bib0015","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1007\/s00125-009-1418-4","article-title":"Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study","volume":"52","author":"Hemkens","year":"2009","journal-title":"Diabetologia"},{"issue":"Suppl. 2","key":"10.1016\/j.drudis.2013.04.005_bib0020","doi-asserted-by":"crossref","first-page":"S262","DOI":"10.2337\/dc08-s264","article-title":"Insulin resistance and hyperinsulinemia: is hyperinsulinemia the cart or the horse?","volume":"31","author":"Shanik","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.drudis.2013.04.005_bib0025","doi-asserted-by":"crossref","first-page":"588","DOI":"10.2337\/diacare.24.3.588","article-title":"Recent advances in our understanding of insulin action and insulin resistance","volume":"24","author":"Le Roith","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.drudis.2013.04.005_bib0030","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1172\/JCI7535","article-title":"Insulin resistance differentially affects the PI 3-kinase-and MAP kinase-mediated signaling in human muscle","volume":"105","author":"Cusi","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.drudis.2013.04.005_bib0035","doi-asserted-by":"crossref","first-page":"14837","DOI":"10.1016\/S0021-9258(18)47871-4","article-title":"Insulin-mimetic effect of trypsin on the insulin receptor tyrosine kinase in intact adipocytes","volume":"262","author":"Leef","year":"1987","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drudis.2013.04.005_bib0040","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1210\/rp.56.1.107","article-title":"Discovery of a small molecule insulin receptor activator","volume":"56","author":"Salituro","year":"2001","journal-title":"Recent Prog. Horm. Res."},{"key":"10.1016\/j.drudis.2013.04.005_bib0045","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1126\/science.284.5416.974","article-title":"Discovery of a small molecule insulin mimetic with antidiabetic activity in mice","volume":"284","author":"Zhang","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.drudis.2013.04.005_bib0050","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/cbic.200200468","article-title":"Signaling effects of demethylasterriquinone B1, a selective insulin receptor modulator","volume":"4","author":"Webster","year":"2003","journal-title":"Chembiochem"},{"key":"10.1016\/j.drudis.2013.04.005_bib0055","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1067\/mva.2000.111280","article-title":"A novel insulin mimetic without a proliferative effect on vascular smooth muscle cells","volume":"32","author":"Weber","year":"2000","journal-title":"J. Vasc. Surg."},{"issue":"Suppl. 1","key":"10.1016\/j.drudis.2013.04.005_bib0060","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.2337\/diabetes.51.2007.S43","article-title":"Effect of the insulin mimetic L-783,281 on intracellular [Ca2+] and insulin secretion from pancreatic \u03b2-cells","volume":"51","author":"Roper","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.drudis.2013.04.005_bib0065","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nm0202-179","article-title":"Small molecule insulin mimetics reduce food intake and body weight and prevent development of obesity","volume":"8","author":"Air","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.drudis.2013.04.005_bib0070","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.1021\/jm000285q","article-title":"Discovery of a potent, highly selective, and orally efficacious small-molecule activator of the insulin receptor","volume":"43","author":"Liu","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drudis.2013.04.005_bib0075","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1042\/bj20020708","article-title":"Regulation of insulin signal transduction pathway by a small-molecule insulin receptor activator","volume":"367","author":"Ding","year":"2002","journal-title":"Biochem. J."},{"key":"10.1016\/j.drudis.2013.04.005_bib0080","doi-asserted-by":"crossref","first-page":"8374","DOI":"10.1021\/jo0204597","article-title":"Synthesis of 2,5-dihydroxy-3-(indol-3-yl)benzoquinones by acid-catalysed condensation of indoles with 2,5-dichlorobenzoquinone","volume":"67","author":"Pirrung","year":"2002","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.drudis.2013.04.005_bib0085","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1124\/jpet.107.126102","article-title":"Identification of novel orally available small molecule insulin mimetics","volume":"323","author":"Lin","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drudis.2013.04.005_bib0090","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2174\/157489106775244073","article-title":"Anti-infective quinone derivatives of recent patents","volume":"1","author":"Koyama","year":"2006","journal-title":"Recent Pat. Anti-infect. Drug Discov."},{"key":"10.1016\/j.drudis.2013.04.005_bib0095","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.cbi.2012.05.001","article-title":"Cytotoxicity of quinone drugs on highly proliferative human leukemia T cells: reactive oxygen species generation and inactive shortened SOD1 isoform implications","volume":"198","author":"Aguilo","year":"2012","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.drudis.2013.04.005_bib0100","unstructured":"Chen, S.S.T. et al. Antidiabetic 4-hydroxy-2-furoic acids. Merck and Co. Inc., Rahway, NJ (US). USP 6,596,760 B1"},{"key":"10.1016\/j.drudis.2013.04.005_bib0105","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/1423-0127-16-68","article-title":"A novel hydroxyfuroic acid compound as an insulin receptor activator. Structure and activity relationship of a prenylindole moiety to insulin receptor activation","volume":"16","author":"Tsai","year":"2009","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.drudis.2013.04.005_bib0110","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.2337\/db07-0739","article-title":"Elevated epidermal growth factor receptor phosphorylation induces resistance artery dysfunction in diabetic db\/db mice","volume":"57","author":"Belmadani","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.drudis.2013.04.005_bib0115","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nrd2792","article-title":"The FGF family: biology, pathophysiology and therapy","volume":"8","author":"Beenken","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.drudis.2013.04.005_bib0120","unstructured":"Pirrung, M.C. Small molecule insulin mimetic absent quinones. USP 2011\/0028519A1"},{"key":"10.1016\/j.drudis.2013.04.005_bib0125","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2174\/157339908786241124","article-title":"A target based therapeutic approach towards diabetes mellitus using medicinal plants","volume":"4","author":"Prabhakar","year":"2008","journal-title":"Curr. Diabetes Rev."},{"key":"10.1016\/j.drudis.2013.04.005_bib0130","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1021\/bi602547m","article-title":"\u03b1-Lipoic acid as a directly binding activator of the insulin receptor: protection from hepatocyte apoptosis","volume":"46","author":"Diesel","year":"2007","journal-title":"Biochemistry"},{"key":"10.1016\/j.drudis.2013.04.005_bib0135","first-page":"1","article-title":"Insulin-mimetic action of rhoifolin and cosmosiin isolated from Citrus grandis (L.) Osbeck leaves: enhanced adiponectin secretion and insulin receptor phosphorylation in 3T3-L1 cells","volume":"2011","author":"Rao","year":"2009","journal-title":"Evidence-Based Complement. Alternat. Med."},{"key":"10.1016\/j.drudis.2013.04.005_bib0140","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/jn\/135.2.165","article-title":"Tannic acid stimulates glucose transport and inhibits adipocyte differentiation in 3T3-L1 cells","volume":"135","author":"Liu","year":"2005","journal-title":"J. Nutr."},{"key":"10.1016\/j.drudis.2013.04.005_bib0145","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1254\/jphs.93.69","article-title":"Activation of insulin receptors by lagerstroemin","volume":"93","author":"Hattori","year":"2003","journal-title":"J. Pharmacol. Sci."},{"issue":"Pt 2","key":"10.1016\/j.drudis.2013.04.005_bib0150","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1042\/BJ20061123","article-title":"Insulin-mimetic and insulin-sensitizing activities of a pentacyclic triterpenoid insulin receptor activator","volume":"403","author":"Jung","year":"2007","journal-title":"Biochem. J."},{"key":"10.1016\/j.drudis.2013.04.005_bib0155","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1021\/cr980427c","article-title":"Vanadium compounds as insulin mimics","volume":"99","author":"Thompson","year":"1999","journal-title":"Chem. Rev."},{"key":"10.1016\/j.drudis.2013.04.005_bib0160","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1758-5996-2-70","article-title":"Trace elements in glucometabolic disorders: an update","volume":"19","author":"Wiernsperger","year":"2010","journal-title":"Diabetol. Metab. Syndr."},{"key":"10.1016\/j.drudis.2013.04.005_bib0165","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0010-8545(02)00302-8","article-title":"Historic perspective and recent developments on the insulin-like actions of vanadium; toward developing vanadium-based drugs for diabetes","volume":"237","author":"Shechter","year":"2003","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.drudis.2013.04.005_bib0170","doi-asserted-by":"crossref","first-page":"6658","DOI":"10.1016\/S0021-9258(18)48292-0","article-title":"Oral administration of vanadate normalizes blood glucose levels in streptozotocin-treated rats. Characterization and mode of action","volume":"262","author":"Meyerovitch","year":"1987","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drudis.2013.04.005_bib0175","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1210\/endo-125-5-2510","article-title":"Long term improvement of glucose homeostasis by vanadate in obese hyperinsulinemic fa\/fa rats","volume":"125","author":"Brichard","year":"1989","journal-title":"Endocrinology"},{"key":"10.1016\/j.drudis.2013.04.005_bib0180","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1172\/JCI115131","article-title":"Vanadate normalizes hyperglycemia in two mouse models of non-insulin-dependent diabetes mellitus","volume":"87","author":"Meyerovitch","year":"1991","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.drudis.2013.04.005_bib0185","first-page":"1410","article-title":"Vanadyl sulfate improves hepatic and muscle insulin sensitivity in type 2 diabetes","volume":"86","author":"Cusi","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.drudis.2013.04.005_bib0190","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1074\/jbc.272.2.843","article-title":"Mechanism of inhibition of protein-tyrosine phosphatases by vanadate and pervanadate","volume":"272","author":"Huyer","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drudis.2013.04.005_bib0195","doi-asserted-by":"crossref","first-page":"6463","DOI":"10.1016\/S0021-9258(18)53274-9","article-title":"Role of cytosolic tyrosine kinase in mediating insulin-like actions of vanadate in rat adipocytes","volume":"268","author":"Shisheva","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drudis.2013.04.005_bib0200","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.2337\/diab.46.11.1684","article-title":"Vanadate activates membranous nonreceptor protein tyrosine kinase in rat adipocytes","volume":"46","author":"Elberg","year":"1997","journal-title":"Diabetes"},{"key":"10.1016\/j.drudis.2013.04.005_bib0205","doi-asserted-by":"crossref","first-page":"4596","DOI":"10.1016\/S0021-9258(17)41818-7","article-title":"Peroxovanadium compounds. A new class of potent phosphotyrosine phosphatase inhibitors which are insulin mimetics","volume":"269","author":"Posner","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drudis.2013.04.005_bib0210","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.drudis.2007.03.011","article-title":"PTP1B as a drug target: recent developments in PTP1B inhibitor discovery","volume":"12","author":"Zhang","year":"2007","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.drudis.2013.04.005_bib0215","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1146\/annurev.pharmtox.42.083001.144616","article-title":"Protein tyrosine phosphatases: structure and function, substrate specificity, and inhibitor development","volume":"42","author":"Zhang","year":"2002","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.drudis.2013.04.005_bib0220","doi-asserted-by":"crossref","first-page":"3814","DOI":"10.1002\/anie.200461517","article-title":"Inhibitors of protein tyrosine phosphatases: next generation drugs?","volume":"44","author":"Bialy","year":"2005","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.drudis.2013.04.005_bib0225","doi-asserted-by":"crossref","first-page":"13420","DOI":"10.1073\/pnas.94.25.13420","article-title":"Identification of a second aryl phosphate-binding site in protein-tyrosine phosphatase 1B: a paradigm for inhibitor design","volume":"94","author":"Puius","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.drudis.2013.04.005_bib0230","doi-asserted-by":"crossref","first-page":"47311","DOI":"10.1074\/jbc.M106568200","article-title":"Acquisition of a specific and potent PTP1B inhibitor from a novel combinatorial library and screening procedure","volume":"276","author":"Shen","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drudis.2013.04.005_bib0235","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.bmcl.2003.11.076","article-title":"Structure based design of a series of potent and selective non peptidic PTP-1B inhibitors","volume":"14","author":"Lau","year":"2004","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.drudis.2013.04.005_bib0240","doi-asserted-by":"crossref","first-page":"26368","DOI":"10.1074\/jbc.273.41.26368","article-title":"Molecular basis for substrate specificity of protein-tyrosine phosphatase 1B","volume":"273","author":"Sarmiento","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drudis.2013.04.005_bib0245","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1021\/jm034088d","article-title":"Selective protein tyrosine phosphatase 1B inhibitors: targeting the second phosphotyrosine binding site with non-carboxylic acid-containing ligands","volume":"46","author":"Liu","year":"2003","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drudis.2013.04.005_bib0250","doi-asserted-by":"crossref","first-page":"4681","DOI":"10.1021\/jm0702478","article-title":"Structure-based optimization of protein tyrosine phosphatase 1B inhibitors: from the active site to the second phosphotyrosine binding site","volume":"50","author":"Wilson","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drudis.2013.04.005_bib0255","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1016\/S0968-0896(02)00176-1","article-title":"Synthesis and biological activity of a novel class of pyridazine analogues as non-competitive reversible inhibitors of protein tyrosine phosphatase 1B (PTP1B)","volume":"10","author":"Liljebris","year":"2002","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.drudis.2013.04.005_bib0260","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/nsmb803","article-title":"Allosteric inhibition of protein tyrosine phosphatase 1B","volume":"11","author":"Wiesmann","year":"2004","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.drudis.2013.04.005_bib0265","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1021\/jm990260v","article-title":"PTP1B inhibition and antihyperglycemic activity in the ob\/ob mouse model of novel 11-arylbenzo [b] naphtho [2,3-d] furans and 11-arylbenzo [b] naphtho [2,3-d] thiophenes","volume":"42","author":"Wrobel","year":"1999","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drudis.2013.04.005_bib0270","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1124\/mol.104.005553","article-title":"Ertiprotafib improves glycemic control and lowers lipids via multiple mechanisms","volume":"67","author":"Erbe","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.drudis.2013.04.005_bib0275","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1016\/j.bmcl.2007.03.001","article-title":"PTP1B inhibitor Ertiprotafib is also a potent inhibitor of I\u03baB kinase \u03b2 (IKK-\u03b2)","volume":"17","author":"Shrestha","year":"2007","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.drudis.2013.04.005_bib0280","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s10555-008-9115-1","article-title":"PTP1B and TC-PTP: regulators of transformation and tumorigenesis","volume":"27","author":"Stuible","year":"2008","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.drudis.2013.04.005_bib0285","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1084\/jem.186.5.683","article-title":"Impaired bone marrow microenvironment and immune function in T cell protein tyrosine phosphatase-deficient mice","volume":"186","author":"You-Ten","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.drudis.2013.04.005_bib0290","doi-asserted-by":"crossref","first-page":"8010","DOI":"10.1074\/jbc.M511827200","article-title":"Conformation-assisted inhibition of protein-tyrosine phosphatase-1B elicits inhibitor selectivity over T-cell protein-tyrosine phosphatase","volume":"281","author":"Asante-Appiah","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drudis.2013.04.005_bib0295","doi-asserted-by":"crossref","first-page":"11357","DOI":"10.1073\/pnas.142298199","article-title":"PTP1B antisense oligonucleotide lowers PTP1B protein, normalizes blood glucose, and improves insulin sensitivity in diabetic mice","volume":"99","author":"Zinker","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.drudis.2013.04.005_bib0300","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1210\/en.2008-0885","article-title":"Inhibition of protein tyrosine phosphatase-1B with antisense oligonucleotides improves insulin sensitivity and increases adiponectin concentrations in monkeys","volume":"150","author":"Swarbrick","year":"2009","journal-title":"Endocrinology"}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644613000998?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644613000998?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T12:14:36Z","timestamp":1761221676000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644613000998"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":60,"journal-issue":{"issue":"15-16","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S1359644613000998"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2013.04.005","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-peptidyl insulin mimetics as a potential antidiabetic agent","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2013.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}